Patent details

Basic Information

Publication number:

EP2307454

WO Application Number:

CH2009000220

Type:

European Patent Granted for NL

Status:

Patent in Force

Publication Title:

Title When Made Available For Viewing:

Reason Lapsed:

Application number:

EP09768693.5

WO Publication Number:

WO2009155724

EPO Publication Language:

English

SPC Number:

301058

First Applicant Residence Country:

Switzerland (CH)

Publications:

Dates

Filing date:

25/06/2009

Grant date:

18/01/2017

EP Publication Date:

13/04/2011

WO Publication Date:

30/12/2009

Claims Translations Received Date:

Claims Translation B1 Received Date:

13/04/2017

Claims Translation B2 Received Date:

Claims Translation B3 Received Date:

Lapsed By Non Payment Annual Fee Date:

Renunciation Date:

NullificationDate:

Published:

Due To Cession Date:

Registration date:

18/01/2017

EP B1 Publication Date:

18/01/2017

EP B2 Publication Date:

EP B3 Publication Date:

Description Translation B1 Received Date:

Description Translation B2 Received Date:

Description Translation B3 Received Date:

Expiration date:

24/06/2029

Lapsed By Expiration Date:

Revocation Date:

Invalidity Date:

Response To Novelty Search Report Received:

Patent Granting Request:

Lapsed date:

Applicant/holder

From:

27/07/2020

 

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Historical Applicant/holder

From:

27/07/2020

To:

27/07/2020

 

Name:

ESBATech, a Novartis Company LLC

Address:

c/o Novartis Pharma AG Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:

18/01/2017

To:

27/07/2020

 

Name:

ESBATech, an Alcon Biomedical Research Unit LLC

Address:

Wagistrasse 21, 8952 SCHLIEREN, Switzerland (CH)

Domicile Holder

Name:

ir. M.F.J.M. Ketelaars c.s.

From:

13/04/2017

Address:

NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)

To:

Inventor

1

Name:

BORRAS, Leonardo

Address:

8952 Schlieren, Switzerland (CH)

2

Name:

URECH, David

Address:

8634 Hombrechtikon, Switzerland (CH)

3

Name:

GUNDE, Tea

Address:

8005 Zürich, Switzerland (CH)

Priority

1

Priority Patent Number:

155041 P

Priority Date:

24/02/2009

Priority Country:

United States of America (US)

2

Priority Patent Number:

133212 P

Priority Date:

25/06/2008

Priority Country:

United States of America (US)

3

Priority Patent Number:

75692 P

Priority Date:

25/06/2008

Priority Country:

United States of America (US)

4

Priority Patent Number:

75697 P

Priority Date:

25/06/2008

Priority Country:

United States of America (US)

Classification

IPC or IDT classification:

A61K 39/395; C07K 16/22;

Publication

Bulletin

1

Bulletin Heading:

CO

Journal edition number:

35/20

Publication date:

26/08/2020

Description:

Changes in the Netherlands Patent Register

2

Bulletin Heading:

CO

Journal edition number:

35/20

Publication date:

26/08/2020

Description:

Changes in the Netherlands Patent Register

3

Bulletin Heading:

EP3

Journal edition number:

17/17

Publication date:

26/04/2017

Description:

European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:

EP2

Journal edition number:

03/17

Publication date:

18/01/2017

Description:

European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:

201708

Publication date:

22/02/2017

Description:

Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:

201703

Publication date:

18/01/2017

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name

Deed Number:

RC202001460A

Date Registered:

27/07/2020

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

ir. M.F.J.M. Ketelaars c.s.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Added Owner(s)

Name:

ESBATech, a Novartis Company LLC

Address:

Wagistrasse 12, 8952, Schlieren, Switzerland (CH)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Change of Address

Change Kind/ Decision Type:

Owner

Deed Number:

RC202001460B

Date Registered:

27/07/2020

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

ir. M.F.J.M. Ketelaars c.s.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Assignment

Deed Number:

RC202001460C

Date Registered:

27/07/2020

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

ir. M.F.J.M. Ketelaars c.s.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Added Owner(s)

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Annual Fee

Annual Fee(s) Due Date:

30/06/2026

Annual Fee Number:

18

Annual Fee Amount:

1200 Euro

Last Annual Payment Date:

26/05/2025

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

1100 Euro

Payer:

Computer Patent Annuities Limited (CPA)

	Filing date	Document type	Document Description	Number of pages	File Type
	19/04/2017	Outgoing Correspondence	Letter no formal defects	1	PDF	/3/8/9/4/2/0800124983/docs/ep09768693.5_1_132068l271.pdf
	13/04/2017	Incoming Correspondence Electronic	Accompanying letter incoming document	2	PDF	/3/8/9/4/2/0800124983/docs/ep09768693.5_0_incomingcorrespondenceelectronic20170413161111789.pdf
	13/04/2017	Claims	First filed claims	6	PDF	/3/8/9/4/2/0800124983/docs/ep09768693.5_2_claims20170413161110351.pdf